Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.
Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.
复制标题
p16 在同时接受 5-氟尿嘧啶、羟基脲、西妥昔单抗和调强放射治疗的局部晚期头颈癌中的预后意义。
DOI：
10.3892/or.2012.1679
复制
发表时间：
2012
期刊：
影响因子：
4.2
通讯作者：
Kao,Johnn
中科院分区：
文献类型：
--
作者：
Tong,CharlesCL;Lau,KHVincent;Rivera,Michael;Cannan,David;Aguirre-Ghiso,Julio;Sikora,AndrewG;Gupta,Vishal;Forsythe,Kevin;Ko,EricC;Misiukiewicz,Krzysztof;Gurudutt,Vivek;Teng,MaritaS;Packer,StuartH;Genden,EricM;Kao,Johnn
